1029 related articles for article (PubMed ID: 19246681)
41. Bone marrow derived stromal cells modified by adenovirus-mediated HIF-1alpha double mutant protect cardiac myocytes against CoCl2-induced apoptosis.
Wang Y; Sun A; Xue J; Feng C; Li J; Wu J
Toxicol In Vitro; 2009 Sep; 23(6):1069-75. PubMed ID: 19520152
[TBL] [Abstract][Full Text] [Related]
42. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
[TBL] [Abstract][Full Text] [Related]
43. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
44. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
[TBL] [Abstract][Full Text] [Related]
45. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
46. Reduction of apoptosis in the amygdala by an A2A adenosine receptor agonist following myocardial infarction.
Boucher M; Wann BP; Kaloustian S; Cardinal R; Godbout R; Rousseau G
Apoptosis; 2006 Jul; 11(7):1067-74. PubMed ID: 16832713
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
48. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
[TBL] [Abstract][Full Text] [Related]
49. GATA-4 is an angiogenic survival factor of the infarcted heart.
Rysä J; Tenhunen O; Serpi R; Soini Y; Nemer M; Leskinen H; Ruskoaho H
Circ Heart Fail; 2010 May; 3(3):440-50. PubMed ID: 20200331
[TBL] [Abstract][Full Text] [Related]
50. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
[TBL] [Abstract][Full Text] [Related]
51. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure.
Imanishi Y; Miyagawa S; Maeda N; Fukushima S; Kitagawa-Sakakida S; Daimon T; Hirata A; Shimizu T; Okano T; Shimomura I; Sawa Y
Circulation; 2011 Sep; 124(11 Suppl):S10-7. PubMed ID: 21911798
[TBL] [Abstract][Full Text] [Related]
52. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
[TBL] [Abstract][Full Text] [Related]
53. Aging mouse hearts are refractory to infarct size reduction with post-conditioning.
Przyklenk K; Maynard M; Darling CE; Whittaker P
J Am Coll Cardiol; 2008 Apr; 51(14):1393-8. PubMed ID: 18387442
[TBL] [Abstract][Full Text] [Related]
54. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
[TBL] [Abstract][Full Text] [Related]
55. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
[TBL] [Abstract][Full Text] [Related]
56. COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
Zhang Z; Vezza R; Plappert T; McNamara P; Lawson JA; Austin S; Praticò D; Sutton MS; FitzGerald GA
Circ Res; 2003 May; 92(10):1153-61. PubMed ID: 12702643
[TBL] [Abstract][Full Text] [Related]
57. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
58. Anti-apoptotic function of gelsolin in fas antibody-induced liver failure in vivo.
Leifeld L; Fink K; Debska G; Fielenbach M; Schmitz V; Sauerbruch T; Spengler U
Am J Pathol; 2006 Mar; 168(3):778-85. PubMed ID: 16507893
[TBL] [Abstract][Full Text] [Related]
59. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
[TBL] [Abstract][Full Text] [Related]
60. Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis.
Jana S; Aujla P; Hu M; Kilic T; Zhabyeyev P; McCulloch CA; Oudit GY; Kassiri Z
FASEB J; 2021 Oct; 35(10):e21932. PubMed ID: 34549830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
